Drawing for MALDI PHARMAPULSE

USPTO serial 79185165

MALDI PHARMAPULSE

Reviewed by CopyMark Law Group

Reg. 5197716Status 708Renewal
Filing date
Status date
Registration date
May 9, 2017
Examiner
GILLES, DEBORAH LYNN MEINERS
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with MALDI PHARMAPULSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul G. Novak

Paul G. Novak Orbit IP LLP10900 Wilshire Blvd.Suite 300Los Angeles, CA 90024

Goods and services

ClassDescriptionStatusFirst use
009Mass spectrometers, particularly time-of-flight mass spectrometer; computer programs and software for assisting in the development of functional assays in the biochemical field; computer programs and computer software for operating mass spectrometers, particularly time-of-flight mass spectrometer; computer programs and computer software for processing, evaluating and displaying data recorded by mass spectrometersACTIVE—
010[ Medical and veterinary diagnostic instruments, in particular mass spectrometers for examining pharmaceutical and biological samples ]SECTION 71 - CANCELLED—
042[ Scientific and technological services for using mass spectrometers, in particular time-of-flight mass spectrometers, in medicine research and medicine development, namely, medical and scientific research in the field of developing functional biochemical assays; scientific and technological services for mass-spectrometric high-throughput analysis of samples, in particular pharmaceutical and biological samples for label-free detection of native substrates and products in functional biochemical assays; design and development of computer programs and computer software for use with the aforesaid goods and services ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 9, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Nov 20, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 23, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 26, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 26, 2024INPCINVALIDATION PROCESSED—
Sep 25, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 24, 2024NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jan 24, 2024C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jan 16, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 9, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
May 9, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 19, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Aug 20, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 29, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 10, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 10, 2017FIMPFINAL DISPOSITION PROCESSED—
Aug 9, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 25, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 9, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 17, 2017GPNXNOTIFICATION PROCESSED BY IB—
Feb 1, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 1, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 9, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Nov 9, 2016CNSLSUSPENSION LETTER WRITTEN—
Oct 21, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2016RFNTREFUSAL PROCESSED BY IB—
May 2, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 2, 2016RFRRREFUSAL PROCESSED BY MPU—
May 1, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 30, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2016DOCKASSIGNED TO EXAMINER—
Mar 29, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 25, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance